Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...

Strengthen regulatory mechanism to ensure safety of drugs, say experts: Gireesh Babu, New Delhi Thursday, October 16, 2025, 08:00 Hrs [IST] With the contaminated cough syrup bring ...

Activating the glucagon-like peptide 1 receptor (GLP-1R) is the mechanism of action of most drugs currently used to treat ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD), announced today that it has published data in the journal Nature Communications ...

While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress ...